Journal article · 2005 · Open access

Perspectives for the management of febrile neutropenic patients with cancer in the 21st century

Nikolaos V. Sipsas, Gerald P. Bodey, Dimitrios P. Kontoyiannis

Cancer, 103(6), 1103–1113 · Published 21 January 2005 · DOI 10.1002/cncr.20890

Open PDFView at the publisherCite this paper

In brief

“Perspectives for the management of febrile neutropenic patients with cancer in the 21st century” is a 2005 journal article by Nikolaos V. Sipsas and 2 co-authors, published in Cancer. OpenAlex counts 179 citations as of 19 November 2026, which puts it in the top 5% of works published in 2005 by citations. It is open access: the full text is free to read at Cancer.

Citations
179
Most cited in
2020 (8)
Field-weighted impact
8.10
References
94
Authors
3

Abstract

Over the past several decades, there has been substantial progress in the management of patients with febrile neutropenia. However, the ever-changing patterns of infection, ecology, and antibiotic-resistance trends do not allow the development of treatment guidelines that could be applied universally. Hence, the institution's predominant pathogens and resistance patterns should guide the empirical choice of antimicrobials. Prompt initiation of antimicrobial therapy remains the gold standard. Monotherapy with the newer broad-spectrum antimicrobials has tended to replace the classic combination therapy. Empirical administration of glycopeptides, such as vancomycin, without documentation of a gram-positive infection is not favored. The development of risk-stratification models has allowed for identification of low-risk patients with additional treatment options, such as early discharge and exclusively outpatient treatment with oral antimicrobials. The initiation of empirical antifungal therapy in persistently febrile neutropenic patients has become common practice, especially recently, since the introduction of new, effective, less toxic antifungal drugs. It is hoped that the development of new nonculture-based diagnostic methods will allow for the early detection of invasive fungal infections and, thus, the replacement of empirical antifungal therapy with pathogen-specific, preemptive therapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sipsas, N. V., Bodey, G. P., & Kontoyiannis, D. P. (2005). Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer, 103(6), 1103–1113. https://doi.org/10.1002/cncr.20890

MLA 9

Sipsas, Nikolaos V., et al. “Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.” Cancer, vol. 103, no. 6, 2005, pp. 1103–1113. https://doi.org/10.1002/cncr.20890.

Chicago

Sipsas, Nikolaos V., Gerald P. Bodey, and Dimitrios P. Kontoyiannis. 2005. “Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.” Cancer 103 (6): 1103–1113. https://doi.org/10.1002/cncr.20890.

Harvard

Sipsas, N. V., Bodey, G. P. and Kontoyiannis, D. P. (2005) ‘Perspectives for the management of febrile neutropenic patients with cancer in the 21st century’, Cancer, 103(6), pp. 1103–1113. doi:10.1002/cncr.20890.

IEEE

N. V. Sipsas, G. P. Bodey, and D. P. Kontoyiannis, “Perspectives for the management of febrile neutropenic patients with cancer in the 21st century,” Cancer, vol. 103, no. 6, pp. 1103–1113, 2005, doi: 10.1002/cncr.20890.

BibTeX

@article{sipsas2005perspectives,
  title     = {{Perspectives for the management of febrile neutropenic patients with cancer in the 21st century}},
  author    = {Sipsas, Nikolaos V. and Bodey, Gerald P. and Kontoyiannis, Dimitrios P.},
  journal   = {Cancer},
  year      = {2005},
  volume    = {103},
  number    = {6},
  pages     = {1103--1113},
  doi       = {10.1002/cncr.20890},
  url       = {https://doi.org/10.1002/cncr.20890}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201766
201877
201944
202088
202155
202288
202333
202477
202544
202622

Its field-weighted citation impact is 8.10: it has been cited 8.10 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • febrile neutropenia
  • cancer patients
  • empirical antimicrobial therapy
  • antibiotic resistance
  • vancomycin
  • glycopeptides
  • risk stratification model
  • outpatient care

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Sipsas, N. V., Bodey, G. P., & Kontoyiannis, D. P. (2005). Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer, 103(6), 1103–1113. https://doi.org/10.1002/cncr.20890

How many times has this paper been cited?

179 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancer: sign in and open the PDF from this page.

Who wrote this paper?

Nikolaos V. Sipsas, Gerald P. Bodey, Dimitrios P. Kontoyiannis.

What is the DOI of this paper?

10.1002/cncr.20890, permanently at https://doi.org/10.1002/cncr.20890. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.